Resources for insight and

inspiration

Tagline

Short heading here

Long subheading lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros.

Short heading here

Subheading one
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros.

Short heading here

Subheading one
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros.

Short heading here

Subheading one
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros.

Insights

Navigating Business Associate Agreements: A Startup Guide for Handling Health Data

If your startup handles healthcare data in any form - through software, services, or analytics - you’ve probably come across the term Business Associate Agreement (BAA). For health tech, digital wellness, and related industries, BAAs are not optional. They are required under HIPAA and are critical to protecting patient information.

Waiver and Release Agreements: A Founder's Guide to Risk Management

Startups move fast - and sometimes things don’t go as planned. Whether you’re resolving a dispute, parting ways with a contractor, or running a risky beta test, a waiver and release agreement can be a key risk management tool.

Commercial Agreements for Startups: A Quick Legal Guide

When your startup starts selling, partnering, or outsourcing - it’s time to start signing commercial agreements. Whether you’re licensing software, onboarding a reseller, or buying cloud services, these contracts govern how your business operates in the real world.

MSAs and SOWs: What Startup Founders Need to Know

When your startup begins signing customers or vendors, two acronyms quickly become part of the conversation: MSA and SOW. These agreements are more than just legal language - they provide the structure that supports many B2B relationships.

Not always, but they are common. Some early-stage investors accept uncapped SAFEs if they have strong conviction in the company.

A cap sets the maximum valuation for conversion, while a discount lowers the share price relative to the next round’s investors. Many instruments include both, and investors convert using whichever is more favorable.

Yes. While ROFRs protect control, they can limit founder or employee liquidity if structured too rigidly. Negotiating carve-outs can help preserve flexibility.

Typically 30–60 days, though shorter timelines may be negotiated to avoid deal delays.

Not always. ROFRs may apply only to certain classes (e.g., preferred stockholders) or exclude transfers such as estate planning or gifts.

A ROFR (Right of First Refusal) allows the company or investors to match a third-party offer. A ROFO (Right of First Offer) requires the shareholder to offer their shares internally before seeking outside buyers.

Yes. Founders often negotiate for higher approval thresholds, equal treatment provisions, and liability caps to ensure fairness.

Most agreements require majority or supermajority consent (often 60 - 70%) from preferred shareholders, though this can vary by deal.

Yes, they typically bind all shareholders—including founders, employees, and option holders - unless carve-outs are negotiated.

Investors use drag-along rights to ensure that all shareholders participate in a sale, avoiding minority holdouts that could block or delay an exit.

Yes. Founders can push for broad-based weighted average terms, carve-outs for employee equity, or even conditional waivers to maintain alignment with investors.

Because it resets the conversion price to the lowest new share price, which can drastically dilute founders and employees even if only a small down round occurs.

The broad-based weighted average formula is the market standard, striking a balance between investor protection and founder dilution.

Issuing new equity at a lower price than earlier rounds (a “down round”) typically triggers the adjustment.

If an investor declines, the company can allocate those shares to other investors or new entrants, sometimes through overallotment provisions.

Yes. In later rounds, rights can often be sold or assigned, especially if the original investor lacks capital reserves.

Yes, most institutional investors request them, especially at seed and Series A. The scope and duration, however, are negotiable.

Founders with equity typically don’t need them, but sometimes advisors, accelerators, or insiders may negotiate for them.

In big exits (10x+ invested capital), liquidation preferences usually have little impact since all parties receive strong returns, but they can still influence exact distributions.

Yes. Founders can negotiate for 1x preferences, caps on participation, or paripassu treatment across rounds to maintain balance.

Filter items
Search items
Schedule a Consultation
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.